FDA Clears First Technology to Distinguish between Bacterial and Viral Infections Using the Body’s Immune Response – The MeMed BV® Test and MeMed Key® Platform

FDA Clears First Technology to Distinguish between Bacterial and Viral Infections Using the Body’s Immune Response – The MeMed BV® Test and MeMed Key® Platform MeMed BV is a first-of-its kind test that decodes the immune response to accurately distinguish between bacterial or viral infections within minutes MeMed Key is a pioneering platform that enables […]

Read More

JEITO CAPITAL BECOMES A KEY PLAYER IN THE FINANCING OF LIFE SCIENCES IN EUROPE WITH THE CLOSING OF JEITO I AT €534 MILLION ($630 MILLION)

JEITO CAPITAL BECOMES A KEY PLAYER IN THE FINANCING OF LIFE SCIENCES IN EUROPE WITH THE CLOSING OF JEITO I AT €534 MILLION ($630 MILLION) Jeito I exceeds target and becomes the largest European fund dedicated to the life sciences sector Jeito Capital is dedicated to working with biotech entrepreneurs to provide financial and expert […]

Read More

Junshi Biosciences Announces Expansion of Emergency Use Authorization for Etesevimab and Bamlanivimab Administered Together to Include Post-Exposure Prophylaxis for COVID-19

SHANGHAI, China, Sept. 19, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the United States Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) for etesevimab (JS016/LY-CoV016) 1,400 mg and bamlanivimab (LY-CoV555) […]

Read More

Tai Ji Men Qigong Academy Members Revisit Honolulu to Continue the Promotion of Love, Peace and Hope

Celebrating the 20th Anniversary of the Proclamation of September 16, 2001 as Tai Ji Men Qigong Academy and Dr. Hong Tao Tze Day in Honolulu Dr. Hong, Tao-Tze Honored for His Peace Efforts in Honolulu in 2001 HONOLULU, Sept. 17, 2021 (GLOBE NEWSWIRE) — To honor the 20th anniversary of the 9/11 attacks, various commemorative […]

Read More

Virgin Pulse Delivers Vaccination Management Solutions to Help Organizations Address and Adhere to New COVID-19 Mandates

Digital Vaccination Card PROVIDENCE. R.I., Sept. 17, 2021 (GLOBE NEWSWIRE) — In response to the Biden Administration’s recent COVID-19 Action Plan rules and international vaccine regulations and mandates, Virgin Pulse, the leading global provider of tech-enabled health, wellbeing and safety solutions, today announced that it has released new Vaccination Management and Mandate Compliance solutions to help organizations around the […]

Read More

Junshi Biosciences and Coherus to Present Positive Progression Free Survival and Overall Survival Results from JUPITER-06, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Advanced Esophageal Squamous Cell Carcinoma

– Interim results to be presented September 17 at the European Society for Medical Oncology (ESMO) Congress 2021 – – Data support the use of toripalimab with chemotherapy as first-line therapy for patients with ESCC – – Coherus and Junshi Biosciences plan to submit a BLA supplement for 1L ESCC in 2022 – SHANGHAI, China, and REDWOOD CITY, Calif., Sept. […]

Read More

Align Technology Introduces First Professional Whitening System Optimized for Invisalign Aligners and Vivera Retainers Powered by Ultradent’s Opalescence Tooth Whitening Systems

‘Invisalign Professional Whitening System – powered by Opalescence’ Align signs multi-year agreement with Ultradent, a leader in tooth whitening for over 30 years, to offer Invisalign trained doctors an exclusive professional whitening system with the leading Opalescence PF whitening formula New Invisalign Professional Whitening System revolutionizes teeth whitening with an all-in-one solution that enables Invisalign […]

Read More